Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11890316 Oral octreotide therapy and contraceptive methods

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
September 9, 2021
0
Date of Patent
February 6, 2024
0
Patent Application Number
17470836
0
Patent Citations
‌
US Patent 7217431 Controlled agglomeration
0
‌
US Patent 7288520 Cyclosporin compositions
0
‌
US Patent 7411039 GLP-2 compounds, formulations, and uses thereof
0
‌
US Patent 7759312 Delivery of dry formulations of octreotide
0
‌
US Patent 8133863 Stabilizing alkylglycoside compositions and methods thereof
0
‌
US Patent 8241670 Compositions capable of facilitating penetration across a biological barrier
0
‌
US Patent 8329198 Pharmaceutical compositions and related methods of delivery
0
‌
US Patent 8535695 Pharmaceutical compositions and related methods of delivery
0
‌
US Patent 8822637 Somatostatin analogues
0
‌
US Patent 8883203 Solid oral dosage form containing an enhancer
0
•••
Patent Inventor Names
Ruth Engle Stevens
0
Asi Haviv
0
Jennings Ray Dawkins
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11890316
0
Patent Primary Examiner
‌
Marcela M Cordero Garcia
0
CPC Code
‌
A61K 45/06
0
‌
A61K 9/48
0
‌
A61K 31/567
0
‌
A61K 38/12
0
‌
A61K 9/0053
0
‌
A61K 38/08
0

Find more entities like US Patent 11890316 Oral octreotide therapy and contraceptive methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.